Home
Biosidus S.A

Biosidus S.A Market Share Analysis for June 2026

biosidus

Industry: N/A

Domainbiosidus.com.ar

Year Founded1983

Employees501 - 1000

Annual Revenue$75M - $100M

Biosidus S.A

Biosidus S.A (including company regionals)

biosidus.com.ar

See more website traffic and engagement information

Biosidus S.A Revenue up to June 2026 is 75M - 100M

revenue generated by Biosidus S.A top domains

Biosidus S.A top domains revenue over 3 years

Revenue for Biosidus S.A top domains

biosidus.com.ar75M - 100M

See more with Sales Intelligence

Total visits to Biosidus S.A's top domains

Understand Biosidus S.A market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biosidus.com.ar6.1K

See more with Sales Intelligence

Avg. visit duration in Biosidus S.A's top domains

Analyze Biosidus S.A engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biosidus.com.ar00:00:39

See more with Sales Intelligence

Avg. pageviews on Biosidus S.A's top domains

See how Biosidus S.A keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biosidus.com.ar1.99

See more with Sales Intelligence

Biosidus S.A top competitors by domain

Top similar sites in June 2026, ranked by their affinity

sidus.com.arCompany NameSidusEmployees501 - 1000HQArgentina, MartinezAnnual revenue$2M - $5MTotal visits22.7KHealth > Health - Other

Top technologies used by Biosidus S.A

These are the website technologies, by industry, used by Biosidus S.A top domains

Payment & Currencies (8)

Cart Functionality

Widget (7)

Twemoji

Advertising (3)

Google Adsense

Audio Video Media (3)

YouTube

More Technologies

8

See all

News & Signals from Biosidus S.A

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMubadalaBio partnered with Biosidus on Jun 24th '26.Mubadala Bio signed a strategic agreement with Biosidus to expand access to biologic therapies through local manufacturing, strengthening regional healthcare resilience while accelerating access to advanced treatments.

NewsPrestige BioPharma Ltd partnered with Biosidus on Nov 26th '25.SINGAPORE, Nov. 26, 2025 /PRNewswire/ - Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue(R)(trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay.

NewsMabxience group partners with Biosidus.mAbxience, a developer and manufacturer of biopharmaceutical products, and part of the Fresenius Kabi and Insud Pharma groups, has entered an agreement with Biosidus, an Argentine company specialized in biotechnology, focused in the area of CDMO (Contract Development and Manufacturing Organization).